DK0736029T3 - Antikonvulsive pseudofructopyranosesulfamater - Google Patents

Antikonvulsive pseudofructopyranosesulfamater

Info

Publication number
DK0736029T3
DK0736029T3 DK95904333T DK95904333T DK0736029T3 DK 0736029 T3 DK0736029 T3 DK 0736029T3 DK 95904333 T DK95904333 T DK 95904333T DK 95904333 T DK95904333 T DK 95904333T DK 0736029 T3 DK0736029 T3 DK 0736029T3
Authority
DK
Denmark
Prior art keywords
pseudofructopyranose
sulfamates
anticonvulsant
disclosed
compound
Prior art date
Application number
DK95904333T
Other languages
Danish (da)
English (en)
Inventor
Samuel O Nortey
Bruce E Maryanoff
Michael J Costanzo
David F Mccomsey
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/337,597 external-priority patent/US5498629A/en
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of DK0736029T3 publication Critical patent/DK0736029T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
  • Confectionery (AREA)
DK95904333T 1993-12-23 1994-12-15 Antikonvulsive pseudofructopyranosesulfamater DK0736029T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17339993A 1993-12-23 1993-12-23
US08/337,597 US5498629A (en) 1993-12-23 1994-11-10 Anticonvulsant pseudofructopyranose sulfamates

Publications (1)

Publication Number Publication Date
DK0736029T3 true DK0736029T3 (da) 2006-05-15

Family

ID=26869093

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95904333T DK0736029T3 (da) 1993-12-23 1994-12-15 Antikonvulsive pseudofructopyranosesulfamater

Country Status (13)

Country Link
EP (1) EP0736029B1 (es)
JP (1) JP3555032B2 (es)
AT (1) ATE319715T1 (es)
AU (1) AU695336B2 (es)
CA (1) CA2179733C (es)
DE (1) DE69434652T2 (es)
DK (1) DK0736029T3 (es)
ES (1) ES2260761T3 (es)
IL (1) IL112098A (es)
NZ (1) NZ277725A (es)
PT (1) PT736029E (es)
RU (1) RU2139875C1 (es)
WO (1) WO1995017406A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6583172B1 (en) * 1999-04-08 2003-06-24 Richard P. Shank Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders
JP2003505465A (ja) 1999-07-26 2003-02-12 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 急性虚血により引き起こされる神経変性の処置において有用な三環式単糖誘導体
MXPA04004380A (es) * 2001-11-06 2005-06-08 Johnson & Johnson Tratamiento y prevencion de parestesia que comprende co-terapia con derivados anticonvulsivos y potasio.
US7060725B2 (en) 2002-05-13 2006-06-13 Janssen Pharmaceutica N.V. Substituted sulfamate anticonvulsant derivatives
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
EP1881959A1 (en) 2005-05-20 2008-01-30 Janssen Pharmaceutica N.V. Process for preparation of sulfamide derivatives
US8492431B2 (en) 2005-12-19 2013-07-23 Janssen Pharmaceutica, N.V. Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
US8716231B2 (en) 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
JP2009537635A (ja) 2006-05-19 2009-10-29 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 癲癇の処置のための共同−療法
US8809385B2 (en) 2008-06-23 2014-08-19 Janssen Pharmaceutica Nv Crystalline form of (2S)-(-)-N-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
US9937145B2 (en) * 2013-12-12 2018-04-10 Bio-Pharm Solutions Co., Ltd. Sulfamate derivative compound for use in preventing or treating epilepsy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US5242942A (en) * 1992-04-28 1993-09-07 Mcneilab, Inc. Anticonvulsant fructopyranose cyclic sulfites and sulfates

Also Published As

Publication number Publication date
CA2179733C (en) 2007-03-27
CA2179733A1 (en) 1995-06-29
EP0736029B1 (en) 2006-03-08
NZ277725A (en) 1998-04-27
IL112098A (en) 1997-07-13
AU1306795A (en) 1995-07-10
JP3555032B2 (ja) 2004-08-18
WO1995017406A1 (en) 1995-06-29
DE69434652T2 (de) 2007-03-01
AU695336B2 (en) 1998-08-13
IL112098A0 (en) 1995-03-15
ATE319715T1 (de) 2006-03-15
ES2260761T3 (es) 2006-11-01
PT736029E (pt) 2006-05-31
RU2139875C1 (ru) 1999-10-20
DE69434652D1 (de) 2006-05-04
JPH09507070A (ja) 1997-07-15
EP0736029A1 (en) 1996-10-09

Similar Documents

Publication Publication Date Title
SE9504661D0 (sv) New compounds
MX9707453A (es) Derivados de quinazolina.
CY1107391T1 (el) Αρυλσυμπυκνωμενες αζαπολυκυκλικες ενωσεις
IL123002A0 (en) 1-Phenyl-2- phenylacetoxy- ethanone derivatives
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
IL123293A (en) Piperidine derivatives, their preparation and pharmaceutical compositions containing them
ES2102475T3 (es) Nuevas alquil-amidas heterociclicas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
NO996108L (no) 9-oksinerytromycinderivater
PT921787E (pt) Regime de administracao de inibidores de atpase de h',k'
EP1026157A3 (en) Method for the synthesis of huperzine A and analogs thereof and compounds useful therein
MD1560G2 (ro) Compuşi ciclici, compoziţii farmaceutice pe baza lor şi metode de tratament al infecţiilor sau bolilor provocate de retrovirusuri
GR1001597B (el) Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών.
EA199801028A1 (ru) Применение производных п-аминофенола для проготовления фармацевтических композиций, используемых при лечении нейродегенеративных заболеваний
LU88843I2 (fr) Ropivacaine et ses dérivés pharmaceutiquement acceptables (Naropine R)
MX9708452A (es) Inhibidores de sialidasa bacteriana y metodos para fabricar y usar la misma.
AP9300561A0 (en) Antibiotic compounds.
CS734389A3 (en) 4-fluoro-2-//(4-methoxy-2-pyridyl)methyl/sulfinyl/ -1h - benzimidazole, process for its production and a pharmaceutical comprising said compound as an active component
HUP9701660A2 (hu) 10,13,15-trioxa-triciklo[9.2.1.1. 9.6]pentadekanon-származékok, eljárás ezek előállítására, és az e vegyületeket tartalmazó gyógyászati készítmények
ES2160308T3 (es) Nuevos derivados amino-metil-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
IT1270905B (it) Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta
SE9504662D0 (sv) New compounds
DE69330601D1 (de) Serotoninergische ergolin derivate
NO993627L (no) Anvendelse av en forbindelse for fremstilling av et legemiddel
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
ES2086195T3 (es) Nuevos derivados pseudopeptidicos de actividad antagonista de la bradiquinina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.